GoKawiilDARPA funds $73M program to develop shelf-stable dried blood products
DARPA has launched a $73 million initiative to create long-lasting, dried versions of plasma, platelets, and red blood cells for battlefield use. The program aims to have these dried blood products ready for field deployment by 2029, though researchers still face open questions about the safety and effectiveness of synthetic blood alternatives.
GoKawiil's interpretation of the reporting above, not reported fact.
Reliable, stable blood products could reduce reliance on refrigerated blood supplies in combat zones, potentially saving lives where traditional blood storage and transport are impractical. The tight 2029 timeline suggests urgency, but unresolved safety and efficacy questions mean the technology's real-world viability remains uncertain.
- DARPA is funding a $73 million effort for shelf-stable dried blood products.
- Target deployment for battlefield use is set for 2029.
- Safety and effectiveness of synthetic blood alternatives still need validation.
Source: technologyreview.com — Thomas Macaulay, 2026-10-14
Published there as: “The Download: faking blood and the future of batteries”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.